Braxia Scientific Corp. (BRAXF)
OTC: BRAXF
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 06, 2025, 10:51 AM
Braxia Scientific Income Statement
Financials in CAD. Fiscal
year is
April - March.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 492.44K | 594.08K | 600.2K | 522.43K | 488.97K | 455.26K | 417.5K | 369.65K | 324.9K | 385.52K | 407.07K | 246.67K | 286.84K | 249.05K | 225.81K |
Cost of Revenue | 410.46K | 589.54K | 733.65K | 1.53M | 1.43M | 1.48M | 857.34K | 982.11K | 1.54M | 1.44M | 807.33K | 286.15K | 265.04K | 245.45K | 165.57K |
Gross Profit | 81.98K | 4.54K | -133.45K | -1.01M | -944.22K | -1.03M | -439.84K | -612.46K | -1.21M | -1.06M | -400.25K | -39.48K | 21.8K | 3.6K | 60.24K |
Operating Income | -977.13K | -259.66K | -789.52K | -2.29M | -2.42M | -1.77M | -948.63K | -1.86M | -2.51M | -1.72M | -1.08M | -2.22M | -1.58M | -2.06M | -4.97M |
Interest Income | n/a | n/a | n/a | 3.17K | 312.18K | 321.98K | n/a | 1.7K | 1K | 1.07K | n/a | 2.83K | 304.00 | n/a | 134.00 |
Pretax Income | -907.05K | -269.36K | -798.47K | -7.79M | -2.18M | -2.35M | -984.57K | -6.88M | -2.51M | -1.71M | -1.08M | -2.22M | -1.54M | -2.05M | -82.76M |
Net Income | -907.05K | -272.83K | -802.25K | -7.66M | -2.17M | -2.34M | -968.84K | -6.81M | -2.52M | -1.71M | -1.09M | -2.59M | -1.54M | -2.05M | -82.76M |
Selling & General & Admin | 639.53K | 264.2K | 637.05K | 1.28M | 1.4M | 745.33K | 491.59K | 1.14M | 1.29M | 647.93K | 579.52K | 1.65M | 817.26K | 1.45M | 4.21M |
Research & Development | n/a | 9.17K | 19.02K | 674.00 | 77.07K | 3.41K | 17.2K | 107.58K | 2.7K | 10.8K | 71.5K | 426.98K | 577.12K | 445.92K | 528.83K |
Other Expenses | 419.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -24.4K | -94.18K | -304 | n/a | n/a |
Operating Expenses | 1.06M | 264.2K | 656.07K | 1.28M | 1.48M | 748.74K | 508.79K | 1.25M | 1.3M | 658.73K | 675.41K | 2.18M | 1.53M | 2.06M | 5.03M |
Interest Expense | 25.67K | 25.88K | 4.2K | 3.1K | n/a | 321.98K | 4.94K | 1.7K | 1K | 1.07K | 1.18K | 1.6K | 304.00 | n/a | 134.00 |
Selling & Marketing Expenses | 14.99K | 16.78K | 21.01K | 38.61K | 35.1K | 58.97K | 19.76K | -77.59K | 148.67K | 73.5K | 108.42K | 623.91K | 105.45K | 514.02K | 603.53K |
Cost & Expenses | 1.47M | 853.74K | 1.39M | 2.81M | 2.91M | 2.23M | 1.37M | 2.23M | 2.83M | 2.1M | 1.48M | 2.46M | 1.79M | 2.3M | 5.2M |
Income Tax Expense | n/a | 3.48K | 3.79K | -145.88K | -6.07K | -8.06K | -15.73K | -45.27K | 11.73K | -2.2K | 14.72K | 376.3K | 934.00 | 27.00 | 134.00 |
Shares Outstanding (Basic) | 263.75M | 263.71M | 263.71M | 263.71M | 240.72M | 225.61M | 198.58M | 170.26M | 168.58M | 168.41M | 169.04M | 177.29M | 177.29M | 177.29M | 107.51M |
Shares Outstanding (Diluted) | 263.71M | 263.71M | 263.71M | 263.71M | 240.72M | 225.61M | 198.58M | 170.26M | 168.58M | 168.41M | 169.04M | 177.29M | 177.29M | 177.29M | 107.51M |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.03 | -0.01 | -0.01 | -0.00 | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.77 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.03 | -0.01 | -0.01 | -0.00 | -0.04 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.77 |
EBITDA | -807.51K | -173.6K | -741.84K | -2.13M | -2.23M | -1.59M | -932.4K | -1.85M | -2.52M | -1.7M | -1.08M | -2.21M | -1.54M | -2.05M | -4.96M |
EBIT | -881.38K | -246.95K | -798.05K | -7.8M | -2.42M | -2.02M | -963.9K | -6.85M | -2.52M | -1.71M | -1.09M | -2.59M | -1.54M | -2.05M | -82.76M |
Depreciation & Amortization | 73.86K | 73.35K | 56.21K | 162.03K | 189.93K | 182.44K | 31.5K | 6.41K | 5.65K | 4.74K | 6.38K | 5.22K | 3.09K | 5.91K | 5.57K |